PML is a tumor suppressor protein as first realized in acute promyelocytic leukemia (APL), where a chromosomal translocation creates a fusion protein with the retinoic acid receptor α, resulting in loss of PML function. The gene discussed is TCHP; the disease is acute promyelocytic leukemia.